BERTopic results plotkins vaccines

Topic 0
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Mf59
  Keywords:          pandemic, influenza, antibody, diversity affinity, influenza vaccine, adjuvanted, antibodies, mf59, diversity, affinity
  Summary:           MF59 was approved only in one vaccine, FLUAD, an influenza vaccine for older adults, and licensed in several European countries from 1997 onward. For an H5N1 pandemic strain, sixfold more antigen was required to induce an immune response to a level equivalent to the seasonal influenza vaccine.

Topic 1
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Adjuvants
  Keywords:          live, relevant, disorders, adjuvants, live attenuated, attenuated, mucosal immunity, vaccines, need, mucosal
  Summary:           Adjuvants are substances that are added to vaccine antigens to enhance and modulate the immunogenicity of the antigen. The use of adjuvants has been known for more than a century, and it is only recently that their mechanism of action was elucidated.

Topic 2
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Saponins
  Keywords:          saponins, cholesterol, saponin, qs-21, mixture, reactogenicity, reactogenic, function, mixture saponins, parent
  Summary:           Saponins are triterpenoid molecules with a complex sugar backbone extracted from a variety of plants. The most widely used of these extracts is the saponin extract from the South American tree Quillaja saponaria Molina, referred to as Quil-A.

Topic 3
  Auto Label:        Squalene
  Descriptive Label: Squalene
  Keywords:          oil, squalene, water, mineral, emulsion, emulsions, water oil, mineral oil, freund, oil water
  Summary:           Oil-in-water emulsions are based on a nonme- tabolizable oil (squalane) The first of this class of adjuvants was the SAF adjuvant made by Syntex Corporation. For therapeutic vaccines, the risk of cysts and the challenges of formulation may be less significant.

Topic 4
  Auto Label:        Receptor
  Descriptive Label: Receptor
  Keywords:          toll, like receptor, toll like, like, receptor, receptor agonists, ship, miyake, relation-, relation- ship
  Summary:           The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relation- ship within the TLR7, 8 and 9 subfamily. Aggregates are the biologically active units of endotoxin.

Topic 5
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Tlr4
  Keywords:          agonists, specificity, synthetic agonist, pertussis, humans, receptor specificity, cell pertussis, synthetic, rodents, analogs
  Summary:           Human, but not murine, TLR4–MD2 transmits proin- flammatory signals. In humans, but less so in rodents, tetraacylated and pentaacylated forms can inhibit the adjuvant activity.

Topic 6
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Alum
  Keywords:          dendritic, situ, precipitation, aluminum, containing adjuvants, dendritic cells, aluminum containing, containing, adsorbed, solution
  Summary:           Alum, which is water-soluble, is chemically aluminum potassium sulfate, AlK(SO4)2. The earliest vaccines containing aluminum adjuvants were prepared by in situ precipitation.

Topic 7
  Auto Label:        Immunol
  Descriptive Label: Immunol – Dna
  Keywords:          cpg, cpg motifs, motifs, bonds, oligonucleotides, cpg containing, species, recognized, odns, differ
  Summary:           Bacterial DNA is recognized by mammalian species as a PAMP and serves as a potent activator in the innate immune system through interaction with the intracellular TLR9. Fragments of bacterial DNA and synthetic single-stranded oligodeoxynucle- otides (ODNs) containing unmethlyated cytosine phosphate guanine (CpG) motifs have also been demonstrated to be powerful adjuvants.

Topic 8
  Auto Label:        Adjuvant
  Descriptive Label: Adjuvant – Adsorption
  Keywords:          electrostatic, adsorption, hydrophobic, iep, attrac-, forces, electrostatic attrac-, hydroxide adjuvant, aluminum hydroxide, hydroxide
  Summary:           The major mechanisms responsi- ble for the adsorption of antigens are electrostatic attraction, hydrophobic forces, and ligand exchange. Electrostatic attraction can be optimized by determining the IEP of the antigen and then selecting an adjuvant that will have the opposite surface charge at the desired pH.

Topic 9
  Auto Label:        Emulsions
  Descriptive Label: Emulsions
  Keywords:          emulsions, water emulsions, oil, water, oil water, effects, aluminium mpl, order, pharm dev, mpl combination
  Summary:           Table 6.4 gives an overview of oil-in-water emulsions used. Fox CB, Lin S, Sivananthan SJ, et al.

Topic 10
  Auto Label:        Adjuvant
  Descriptive Label: Adjuvant – Aluminium
  Keywords:          surface, surface area, oxyhydroxide, area, groups, aluminum oxyhydroxide, phosphate, aluminum, aluminum phosphate, surface charge
  Summary:           Aluminum hydroxide adjuvant is not Al(OH)3, but rather crystalline aluminum oxyhydroxide (AlOOH) This difference is important because crystalline aluminium hydroxides has a low surface area (approximately 20 to 50 m2/g) and as such is a poor adsorbent. The high surface area is a result of its morphology.

Topic 11
  Auto Label:        Paralysis
  Descriptive Label: Paralysis
  Keywords:          oral, coli, toxin, intranasal, mutant, heat, exotoxins, facial, paralysis, gm1
  Summary:           Mutations have been introduced in an attempt to reduce their toxicity while aiming to retain some adjuvant activity. These include adjuvants such as mLT(R192G), dmLT,153 and LTK63.

Topic 12
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Polyelectrolytes
  Keywords:          polymers, polymer, polyoxidonium, polyelectrolytes, ethylene, polyphosphazenes, aforementioned categories, saponins mecha-, properties.142, poly-
  Summary:           Polyelectrolytes, a class of polymers that includes polyoxidonium and polyphosphazenes, are being evaluated in several clinical trials. Several other adjuvants are in advanced clinical development and do not fall into any of these categories.

Topic 13
  Auto Label:        Anti
  Descriptive Label: Anti
  Keywords:          extensive clinical, extensive, dellagostin, vaccines extensive, wide range, sérum antidiphtérique, studies wide, bull soc, soc centr, centr med
  Summary:           Currently 10 adjuvants are approved for use in vaccines Despite extensive clinical studies with a wide range of anti- as adjuvant in licensed and investigational vaccines. This section is limited to a review of the types of adjuvanted that are incorporated in licensed

Topic 14
  Auto Label:        Malaria
  Descriptive Label: Malaria – Plasmodium
  Keywords:          blood stage, circumsporozoite protein, alhydrogel, blood, circumsporozoite, alhydrogel cpg, stage, plasmodium, malaria, fragment
  Summary:           Plasmodium falciparum malaria vaccine can- didate apical membrane antigen 1 in Montanide ISA720 adju- vant. OM-174, a new adjuvant with a potential for human use.

Topic 15
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Polyarginine
  Keywords:          cationic, cationic peptide, based adjuvant, peptide, cmi, dependent, humoral, mode, mode action, t cell
  Summary:           Poly(dI:dC), a DNA version of the well- known TLR3 agonist poly(I:C), is also a potent adjuvant, acting through the TLR9/MyD88-dependent pathway. Polycations such as polyarginine,145 chitosan,146,147 and cat- ionic lipids148 have also been shown to exert adjUvant activity.

Topic 16
  Auto Label:        Immune
  Descriptive Label: Immune – Immunity
  Keywords:          populations, protection, response, immune response, increase, number doses, responsive populations, cmi critical, duration, response cell-
  Summary:           enhance specific arms of the immune response such as cell- mediated immunity (CMI), a critical target for many of the remaining infectious diseases for which we do not have vaccines. provide a strong priming response in naïve populations, effectively reducing the number of doses required

Topic 17
  Auto Label:        Influenza
  Descriptive Label: Influenza
  Keywords:          elderly adults, elderly, influenza, influenza vaccine, adjuvanted influenza, adjuvanted, mf59, vaccine non, inactivated, - adjuvanted
  Summary:           FLUAD, the MF59-containing seasonal influenza vaccine that has been licensed in numerous countries for the past decade, has been shown to enhance the immune response in this nonresponder population. A similar candidate vaccine using the AS03 oil-in-water emul- sion has been tested in elderly adults.

Topic 18
  Auto Label:        Lipid
  Descriptive Label: Lipid
  Keywords:          lipid, toxic, hydrolysis, mpla, significantly toxic, reduced pyrogenicity, removed, pyrogenicity, pyrogenic, ecule
  Summary:           Lipid A, a major component of the outer membrane of Gram-negative bacteria, has long been known to be a potent stimulator of the immune system. Its use in adjuvants has been curtailed by its toxic effects.

Topic 19
  Auto Label:        Narcolepsy
  Descriptive Label: Narcolepsy
  Keywords:          narcolepsy, risk, benefit risk, vaccinated, cases narcolepsy, risk profile, positive, pandemic, adjuvanted, increased
  Summary:           An increased number of cases of narcolepsy has been reported in children and adolescents vaccinated with an AS03-adjuvanted H1N1 pandemic vaccine in three northern European coun- tries. The CHMP acknowledged that further research in the areas of genetic and environmental factors need to be explored before definitive con- clusions can be drawn.

Topic 20
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Cpg
  Keywords:          seroprotection, sequence, cpg, infected, cpg referred, performed commonly, rapid long, commonly sequence, sequence cpg, iss
  Summary:           CpG has been evaluated with and without alum for malaria vaccines,104,105 conjugate pneumonia vaccines,106 and hepatitis B vaccines107,108 and in HIV-infected patients in whom CpG permits rapid and long-term seroprotection.

Topic 21
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Hiv
  Keywords:          dd, receptor agonist, infected, -, montanide isa, envelope, trial multi, conjugate vaccine, glycoproteins, combined montanide
  Summary:           A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers.

Topic 22
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Cervi
  Keywords:          hpv, cancer, cervi- cal, human papil-, lomavirus hpv)-16/18, as04 adjuvanted, hpv)-16/18, lomavirus, papil-, hpv)-16/18 as04
  Summary:           Cervarix is aimed at pre- venting HPV infection and subsequent development of cervi- cal cancer. Extensive clinical trials demonstrated an acceptable safety profile and efficacy of the vaccine.

Topic 23
  Auto Label:        Directions
  Descriptive Label: Directions
  Keywords:          references, chapter available, references chapter, acknowledgment references, directions acknowledgment, future directions, acknowledgment, directions, available references, chapter
  Summary:           Acknowledgment References

Topic 24
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Iscom
  Keywords:          formula-, safety human, success, studies hum, relies, hum, le based, vaccines second, second decade, decade immunol
  Summary:           ISCOM technology-based matrix M adjuvant: success in future vaccines relies on formula- tion.

Topic 25
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Alum – T25
  Keywords:          membrane lipids, nalp3, dendritic, inflamma-, lipids, identified, dendritic cells, alum, interact directly, alum mechanism
  Summary:           Alum crystals interact directly with membrane lipids on the surface of dendritic cells. The resulting lipid sorting triggers signaling cascades, independent of the inflamma- some, that promote CD4+ T-cell activation.

Topic 26
  Auto Label:        Virosomes
  Descriptive Label: Virosomes
  Keywords:          virosomes, liposomes, encapsulate, liposomal, liposomes virosomes, liposomal membrane, licensed, form nanospheres, consist lipid, ing viral
  Summary:           In the 1970s liposomes and virosomes that adsorb or encapsulate antigen were developed. Liposomes consist of lipid layers that form nanospheres or microspheres.

Topic 27
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Categorization
  Keywords:          adjuvants classification, evaluation categorization, action adjuvants, based mechanism, categorization adjuvants, defining adjuvants, adjuvants defining, discovery adjuvants, necessity discovery, adjuvants adjuvants
  Summary:           A Categorization of Adjuvants Based on Mechanism

Topic 28
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Flagella
  Keywords:          influenza, fusion, flagellin, influenza vaccine, recombinant, hemag-, protein polymerizes, serves adjuvant, adjuvant enhancing, flagella flagellated
  Summary:           Flagellin is a protein that polymerizes to form the flagella of flagellated bacteria and is recognized by TLR5. This protein has been expressed as a fusion partner to influenza hemag- glutinin or influenza M2e, in which it serves as an adjuvant.

Topic 29
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Emulsions
  Keywords:          emulsion, lipid adjuvant, context, stable, acyl chain, chain, glucopyranosyl, glucopyranosyl lipid, acyl, water emulsion
  Summary:           Other emulsions are under development, such as SE (stable emulsion), a squalene-based emulsion. CoVaccine is an experimental adju- vant comprising sucrose fatty acid sulfate ester, combined with squalane.

Topic 30
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Adjuvants – T30
  Keywords:          mmf, committee, lesions, containing vaccines, aluminum, established, presence, practices, persistent, involving
  Summary:           Aluminum salts as adjuvants have the longest and largest safety track record of all adjuvanted vaccines. More than 3 billion vaccine doses used during the past 80 years with a positive risk-to- benefit ratio.

Topic 31
  Auto Label:        Immune
  Descriptive Label: Immune – Adjuvants
  Keywords:          vehicles, α tocopherol, α, apcs, tocopherol, oil, emulsions, adjuvants according, directly immune, primarily
  Summary:           The majority of adjuvant reviews during recent decades have tried to classify adjuvants according to their mechanism of action. It is now known that most of the vehicles act directly on the immune system.

Topic 32
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Adjuvant
  Keywords:          safe, adjuvant evaluation, evaluation, marketing, define real, profile define, molecule adjuvant, vivo safety, value molecule, evaluation compound
  Summary:           It cannot be assumed that an adjuvant that is safe in one vaccine with a given antigen will be safe when added to another vaccine. A rational approach requires nonclini- cal toxicology, determination of the mode of action and controlled clinical trials.

Topic 33
  Auto Label:        Rna
  Descriptive Label: Rna
  Keywords:          factor, interferon, interleukin, tumor necrosis, necrosis factor, factor tnf)-α, receptor associated, necrosis, tnf)-α, helper
  Summary:           Different pathogen-derived signals induce proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, or type 1 interferon. This leads to a predominantly T-helper cell 1 (Th1) response.

Topic 34
  Auto Label:        Immunol
  Descriptive Label: Immunol – Tlr4
  Keywords:          adaptor, signaling, lps, pathway, - binding, lps -, activates, distinct, discovery, binding protein
  Summary:           TLR4 receptor is unique among the TLRs by its ability to induce two distinct signaling pathways. The activation of these pathways is dependent on the structure of the agonist, where minor changes in the number and length of the acyl chains can have a major effect on pathway activation.

Topic 35
  Auto Label:        Malaria
  Descriptive Label: Malaria – Vaccine
  Keywords:          rts, rts s, s, malaria, vaccine date, s phase, iii clinical, dren e18891, date rts, 2009;4 benns
  Summary:           The malaria vaccine candi- date RTS,S/AS is in phase III clinical trials [in French]. Ann Pharm Fr.

Topic 36
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Immune
  Keywords:          mechanisms, hypothesis, depot mechanism, proposed, depot, observation, injection, aluminum containing, containing adjuvants, aluminum salt
  Summary:           There is still no consensus regarding the mechanisms by which aluminum-containing adjuvants potentiate the immune response. The depot mechanism was initially thought of as the dominant one.

Topic 37
  Auto Label:        Immunization
  Descriptive Label: Immunization
  Keywords:          tlr7, tlr7 tlr8, nists, ago-, tlr8, ago- nists, molecules adjuvants, treatment, molecules, topical
  Summary:           Numerous small molecules have been found to act as ago- nists of TLR7 and TLR8. The best known of these are the small-molecule nucleoside analogs, imiquimod and resiqui- mod (R-848),117,118.

Topic 38
  Auto Label:        Vaccines
  Descriptive Label: Vaccines – Freezing
  Keywords:          freezing, effect freezing, temperature, salts, aluminum, coagulates, excursion, richman, erties different, suspected exposed
  Summary:           Freezing may affect the aluminum-containing adjuvant and the adsorbed antigen. Coagulates, which cannot be redispersed by shaking, form when aluminum- containing adjuvants are frozen.

Topic 39
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Gupta
  Keywords:          white, techniques characterize, techniques, compounds pharm, calcium compounds, hem.21, gupta, aluminum calcium, relyveld, calcium
  Summary:           21 Gupta RK, Rost BE, Relyveld E, et al. Adjuvant

Topic 40
  Auto Label:        Tlrs
  Descriptive Label: Tlrs
  Keywords:          pathogen, receptors, pathogen associated, patterns, fig, arms immune, arms, components, different, bacterial
  Summary:           The immune system uses pathogen-associated molecular patterns (PAMPs) to activate receptors such as TLR. These receptors bind various pathogen ligands to trigger different types of immune responses.

Topic 41
  Auto Label:        Tlr4
  Descriptive Label: Tlr4
  Keywords:          immunotherapeutics, sible produce, agonist active, vaccine human, adjuvant trif, vaccine cervarix, biased agonist, molecule new, active glycolipids, glycolipids vaccine
  Summary:           Mono- phosphoryl lipid (MPL) A was the first new adjuvant in a vaccine. It retained the immune poten- tiation activity of LPS without the associated toxicity.

Topic 42
  Auto Label:        Mucosal
  Descriptive Label: Mucosal
  Keywords:          mucosal, mucosal adjuvants, ready clinical, ready, ct, vaccines nontoxic, mucosal adjuvant, mccluskie mucosal, nontoxic derivatives, derivatives ct
  Summary:           Pizza M, Giuliani MM, Fontana MR, et al. LTK63 and LTR72, two mucosal adjuvants

Topic 43
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Adju
  Keywords:          adjuvants centuries, evolution adjuvants, centuries, evolution, centuries evolution, adjuvants, , , , 
  Summary:           Evolution of Adju

Topic 44
  Auto Label:        Adjuvants
  Descriptive Label: Adjuvants – Immunopotentiation
  Keywords:          toxoid precipitated, mechanism immunopotentiation, bacteriol mechanism, alum bacteriol, immunopotentiation safety, value toxoid, antigenic value, immunopotentiation, bacteriol, precipitated
  Summary:           Hogenesch H. Mechanism of immunopotentiation and safety of aluminum

Topic 45
  Auto Label:        Med
  Descriptive Label: Med
  Keywords:          med identifier, identifier, med, , , , , , , 
  Summary:           N Engl J Med.


Document-Level Assignments:
Doc 1: Topic 43 (Auto: Adjuvants; Descriptive: Adjuvants – Adju), Prob: 1.00000000
Doc 2: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 3: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 4: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 1.00000000
Doc 5: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 1.00000000
Doc 6: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 0.80362876
Doc 7: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 1.00000000
Doc 8: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 0.90577613
Doc 9: Topic 16 (Auto: Immune; Descriptive: Immune – Immunity), Prob: 0.90577613
Doc 10: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 11: Topic 27 (Auto: Adjuvants; Descriptive: Adjuvants – Categorization), Prob: 1.00000000
Doc 12: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 13: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 14: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 15: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.24998044
Doc 16: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.44807436
Doc 17: Topic 26 (Auto: Virosomes; Descriptive: Virosomes), Prob: 0.40314204
Doc 18: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 19: Topic 34 (Auto: Immunol; Descriptive: Immunol – Tlr4), Prob: 1.00000000
Doc 20: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 21: Topic 41 (Auto: Tlr4; Descriptive: Tlr4), Prob: 1.00000000
Doc 22: Topic 23 (Auto: Directions; Descriptive: Directions), Prob: 1.00000000
Doc 23: Topic 22 (Auto: Vaccines; Descriptive: Vaccines – Cervi), Prob: 1.00000000
Doc 24: Topic 40 (Auto: Tlrs; Descriptive: Tlrs), Prob: 1.00000000
Doc 25: Topic 33 (Auto: Rna; Descriptive: Rna), Prob: 1.00000000
Doc 26: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 27: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 0.92633792
Doc 28: Topic 33 (Auto: Rna; Descriptive: Rna), Prob: 1.00000000
Doc 29: Topic 43 (Auto: Adjuvants; Descriptive: Adjuvants – Adju), Prob: 1.00000000
Doc 30: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 31: Topic 32 (Auto: Vaccine; Descriptive: Vaccine – Adjuvant), Prob: 1.00000000
Doc 32: Topic 27 (Auto: Adjuvants; Descriptive: Adjuvants – Categorization), Prob: 1.00000000
Doc 33: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 0.56844661
Doc 34: Topic 27 (Auto: Adjuvants; Descriptive: Adjuvants – Categorization), Prob: 1.00000000
Doc 35: Topic 31 (Auto: Immune; Descriptive: Immune – Adjuvants), Prob: 1.00000000
Doc 36: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 0.48134717
Doc 37: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 0.71119312
Doc 38: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 0.48441273
Doc 39: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 40: Topic 39 (Auto: Adjuvants; Descriptive: Adjuvants – Gupta), Prob: 1.00000000
Doc 41: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.80005958
Doc 42: Topic 38 (Auto: Vaccines; Descriptive: Vaccines – Freezing), Prob: 1.00000000
Doc 43: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 0.84157282
Doc 44: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 1.00000000
Doc 45: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 46: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 0.66157008
Doc 47: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 0.82295803
Doc 48: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 1.00000000
Doc 49: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 1.00000000
Doc 50: Topic 39 (Auto: Adjuvants; Descriptive: Adjuvants – Gupta), Prob: 1.00000000
Doc 51: Topic 38 (Auto: Vaccines; Descriptive: Vaccines – Freezing), Prob: 1.00000000
Doc 52: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.97295496
Doc 53: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.57867090
Doc 54: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.39064359
Doc 55: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.54118907
Doc 56: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 1.00000000
Doc 57: Topic 36 (Auto: Adjuvants; Descriptive: Adjuvants – Immune), Prob: 0.80208758
Doc 58: Topic 36 (Auto: Adjuvants; Descriptive: Adjuvants – Immune), Prob: 1.00000000
Doc 59: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.74490861
Doc 60: Topic 25 (Auto: Adjuvants; Descriptive: Adjuvants – Alum – T25), Prob: 1.00000000
Doc 61: Topic 25 (Auto: Adjuvants; Descriptive: Adjuvants – Alum – T25), Prob: 1.00000000
Doc 62: Topic 36 (Auto: Adjuvants; Descriptive: Adjuvants – Immune), Prob: 1.00000000
Doc 63: Topic 30 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants – T30), Prob: 0.76537961
Doc 64: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 1.00000000
Doc 65: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.31404243
Doc 66: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 1.00000000
Doc 67: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.35603687
Doc 68: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 1.00000000
Doc 69: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.44912271
Doc 70: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 1.00000000
Doc 71: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 72: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 73: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.23382589
Doc 74: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 0.42543170
Doc 75: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.24998044
Doc 76: Topic 27 (Auto: Adjuvants; Descriptive: Adjuvants – Categorization), Prob: 0.23348252
Doc 77: Topic 29 (Auto: Vaccine; Descriptive: Vaccine – Emulsions), Prob: 0.81831794
Doc 78: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 1.00000000
Doc 79: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 0.56844661
Doc 80: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 81: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 82: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 83: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 1.00000000
Doc 84: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 85: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 86: Topic 31 (Auto: Immune; Descriptive: Immune – Adjuvants), Prob: 0.95417457
Doc 87: Topic 31 (Auto: Immune; Descriptive: Immune – Adjuvants), Prob: 1.00000000
Doc 88: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 1.00000000
Doc 89: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 90: Topic 19 (Auto: Narcolepsy; Descriptive: Narcolepsy), Prob: 1.00000000
Doc 91: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 92: Topic 19 (Auto: Narcolepsy; Descriptive: Narcolepsy), Prob: 0.09644228
Doc 93: Topic 19 (Auto: Narcolepsy; Descriptive: Narcolepsy), Prob: 1.00000000
Doc 94: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.62100251
Doc 95: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 96: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 97: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 98: Topic 18 (Auto: Lipid; Descriptive: Lipid), Prob: 1.00000000
Doc 99: Topic 22 (Auto: Vaccines; Descriptive: Vaccines – Cervi), Prob: 0.35405179
Doc 100: Topic 34 (Auto: Immunol; Descriptive: Immunol – Tlr4), Prob: 1.00000000
Doc 101: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 102: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 103: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 104: Topic 29 (Auto: Vaccine; Descriptive: Vaccine – Emulsions), Prob: 1.00000000
Doc 105: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 106: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 0.93768278
Doc 107: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 108: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 109: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 110: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 111: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 112: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 113: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 114: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.55995676
Doc 115: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 1.00000000
Doc 116: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.38347827
Doc 117: Topic 20 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 0.46488274
Doc 118: Topic 22 (Auto: Vaccines; Descriptive: Vaccines – Cervi), Prob: 0.35405179
Doc 119: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 120: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 1.00000000
Doc 121: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 122: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 123: Topic 28 (Auto: Vaccine; Descriptive: Vaccine – Flagella), Prob: 1.00000000
Doc 124: Topic 37 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 125: Topic 27 (Auto: Adjuvants; Descriptive: Adjuvants – Categorization), Prob: 0.43597115
Doc 126: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 0.49342937
Doc 127: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 128: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 129: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 130: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 131: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 0.68659250
Doc 132: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 133: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 0.59867609
Doc 134: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 135: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 136: Topic 26 (Auto: Virosomes; Descriptive: Virosomes), Prob: 1.00000000
Doc 137: Topic 26 (Auto: Virosomes; Descriptive: Virosomes), Prob: 1.00000000
Doc 138: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 0.64317159
Doc 139: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 0.58697408
Doc 140: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 0.68397635
Doc 141: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 142: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 0.22941319
Doc 143: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 1.00000000
Doc 144: Topic 23 (Auto: Directions; Descriptive: Directions), Prob: 1.00000000
Doc 145: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 146: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 147: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 148: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 149: Topic 32 (Auto: Vaccine; Descriptive: Vaccine – Adjuvant), Prob: 0.28576542
Doc 150: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 151: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 152: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 153: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 0.79343790
Doc 154: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 155: Topic 23 (Auto: Directions; Descriptive: Directions), Prob: 0.96574595
Doc 156: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 157: Topic 23 (Auto: Directions; Descriptive: Directions), Prob: 0.73015318
Doc 158: Topic 23 (Auto: Directions; Descriptive: Directions), Prob: 0.99852566
Doc 159: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 1.00000000
Doc 160: Topic 44 (Auto: Adjuvants; Descriptive: Adjuvants – Immunopotentiation), Prob: 1.00000000
Doc 161: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 162: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 163: Topic 34 (Auto: Immunol; Descriptive: Immunol – Tlr4), Prob: 0.84609104
Doc 164: Topic 33 (Auto: Rna; Descriptive: Rna), Prob: 1.00000000
Doc 165: Topic 18 (Auto: Lipid; Descriptive: Lipid), Prob: 0.68519714
Doc 166: Topic 33 (Auto: Rna; Descriptive: Rna), Prob: 1.00000000
Doc 167: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 168: Topic 40 (Auto: Tlrs; Descriptive: Tlrs), Prob: 1.00000000
Doc 169: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 170: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 171: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 0.48417491
Doc 172: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 173: Topic 32 (Auto: Vaccine; Descriptive: Vaccine – Adjuvant), Prob: 1.00000000
Doc 174: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 175: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 1.00000000
Doc 176: Topic 10 (Auto: Adjuvant; Descriptive: Adjuvant – Aluminium), Prob: 0.30323071
Doc 177: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.36261768
Doc 178: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 1.00000000
Doc 179: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.92028259
Doc 180: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 181: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 1.00000000
Doc 182: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 0.91996345
Doc 183: Topic 8 (Auto: Adjuvant; Descriptive: Adjuvant – Adsorption), Prob: 1.00000000
Doc 184: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.92213941
Doc 185: Topic 39 (Auto: Adjuvants; Descriptive: Adjuvants – Gupta), Prob: 1.00000000
Doc 186: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 187: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.82029760
Doc 188: Topic 25 (Auto: Adjuvants; Descriptive: Adjuvants – Alum – T25), Prob: 0.89193584
Doc 189: Topic 25 (Auto: Adjuvants; Descriptive: Adjuvants – Alum – T25), Prob: 1.00000000
Doc 190: Topic 44 (Auto: Adjuvants; Descriptive: Adjuvants – Immunopotentiation), Prob: 1.00000000
Doc 191: Topic 25 (Auto: Adjuvants; Descriptive: Adjuvants – Alum – T25), Prob: 0.98988289
Doc 192: Topic 30 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants – T30), Prob: 1.00000000
Doc 193: Topic 30 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants – T30), Prob: 0.64795172
Doc 194: Topic 30 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants – T30), Prob: 1.00000000
Doc 195: Topic 38 (Auto: Vaccines; Descriptive: Vaccines – Freezing), Prob: 1.00000000
Doc 196: Topic 6 (Auto: Adjuvants; Descriptive: Adjuvants – Alum), Prob: 0.89356732
Doc 197: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 198: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 0.89873876
Doc 199: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 0.89873876
Doc 200: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 201: Topic 31 (Auto: Immune; Descriptive: Immune – Adjuvants), Prob: 0.95417457
Doc 202: Topic 21 (Auto: Vaccine; Descriptive: Vaccine – Hiv), Prob: 1.00000000
Doc 203: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 0.64809899
Doc 204: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 205: Topic 1 (Auto: Vaccines; Descriptive: Vaccines – Adjuvants), Prob: 1.00000000
Doc 206: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 0.53351411
Doc 207: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 0.92433050
Doc 208: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 209: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 210: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 0.40713438
Doc 211: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 212: Topic 9 (Auto: Emulsions; Descriptive: Emulsions), Prob: 0.50973545
Doc 213: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 214: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 215: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 216: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 217: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 0.72176461
Doc 218: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 219: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 220: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 1.00000000
Doc 221: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 1.00000000
Doc 222: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 223: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 224: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 225: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 226: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.23492565
Doc 227: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 228: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 0.35129614
Doc 229: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 1.00000000
Doc 230: Topic 19 (Auto: Narcolepsy; Descriptive: Narcolepsy), Prob: 1.00000000
Doc 231: Topic 19 (Auto: Narcolepsy; Descriptive: Narcolepsy), Prob: 0.73573523
Doc 232: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 233: Topic 3 (Auto: Squalene; Descriptive: Squalene), Prob: 1.00000000
Doc 234: Topic 29 (Auto: Vaccine; Descriptive: Vaccine – Emulsions), Prob: 0.81831794
Doc 235: Topic 18 (Auto: Lipid; Descriptive: Lipid), Prob: 1.00000000
Doc 236: Topic 18 (Auto: Lipid; Descriptive: Lipid), Prob: 1.00000000
Doc 237: Topic 22 (Auto: Vaccines; Descriptive: Vaccines – Cervi), Prob: 1.00000000
Doc 238: Topic 22 (Auto: Vaccines; Descriptive: Vaccines – Cervi), Prob: 1.00000000
Doc 239: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 240: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 241: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 242: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 243: Topic 41 (Auto: Tlr4; Descriptive: Tlr4), Prob: 1.00000000
Doc 244: Topic 34 (Auto: Immunol; Descriptive: Immunol – Tlr4), Prob: 0.74595403
Doc 245: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 0.80368586
Doc 246: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 1.00000000
Doc 247: Topic 41 (Auto: Tlr4; Descriptive: Tlr4), Prob: 1.00000000
Doc 248: Topic 20 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 1.00000000
Doc 249: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 250: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 1.00000000
Doc 251: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 0.85213709
Doc 252: Topic 29 (Auto: Vaccine; Descriptive: Vaccine – Emulsions), Prob: 1.00000000
Doc 253: Topic 21 (Auto: Vaccine; Descriptive: Vaccine – Hiv), Prob: 0.62286186
Doc 254: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 0.92572573
Doc 255: Topic 18 (Auto: Lipid; Descriptive: Lipid), Prob: 0.54655289
Doc 256: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 0.66791742
Doc 257: Topic 5 (Auto: Vaccines; Descriptive: Vaccines – Tlr4), Prob: 1.00000000
Doc 258: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.30258821
Doc 259: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.41016355
Doc 260: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 1.00000000
Doc 261: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 1.00000000
Doc 262: Topic 7 (Auto: Immunol; Descriptive: Immunol – Dna), Prob: 0.38347827
Doc 263: Topic 42 (Auto: Mucosal; Descriptive: Mucosal), Prob: 1.00000000
Doc 264: Topic 24 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 0.49934182
Doc 265: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 1.00000000
Doc 266: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 1.00000000
Doc 267: Topic 21 (Auto: Vaccine; Descriptive: Vaccine – Hiv), Prob: 0.62683430
Doc 268: Topic 20 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 0.84215758
Doc 269: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 270: Topic 20 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 1.00000000
Doc 271: Topic 37 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 272: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 0.66035517
Doc 273: Topic 15 (Auto: Vaccine; Descriptive: Vaccine – Polyarginine), Prob: 1.00000000
Doc 274: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 275: Topic 28 (Auto: Vaccine; Descriptive: Vaccine – Flagella), Prob: 1.00000000
Doc 276: Topic 28 (Auto: Vaccine; Descriptive: Vaccine – Flagella), Prob: 0.54780630
Doc 277: Topic 28 (Auto: Vaccine; Descriptive: Vaccine – Flagella), Prob: 1.00000000
Doc 278: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 279: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 280: Topic 4 (Auto: Receptor; Descriptive: Receptor), Prob: 0.98316576
Doc 281: Topic 40 (Auto: Tlrs; Descriptive: Tlrs), Prob: 1.00000000
Doc 282: Topic 20 (Auto: Vaccine; Descriptive: Vaccine – Cpg), Prob: 1.00000000
Doc 283: Topic 14 (Auto: Malaria; Descriptive: Malaria – Plasmodium), Prob: 0.80368586
Doc 284: Topic 37 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 285: Topic 24 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 1.00000000
Doc 286: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 287: Topic 24 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 0.77097052
Doc 288: Topic 24 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 0.90540109
Doc 289: Topic 24 (Auto: Vaccines; Descriptive: Vaccines – Iscom), Prob: 1.00000000
Doc 290: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 291: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 292: Topic 35 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 293: Topic 35 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 294: Topic 35 (Auto: Malaria; Descriptive: Malaria – Vaccine), Prob: 1.00000000
Doc 295: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 0.59354939
Doc 296: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 297: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 298: Topic 2 (Auto: Vaccine; Descriptive: Vaccine – Saponins), Prob: 1.00000000
Doc 299: Topic 45 (Auto: Med; Descriptive: Med), Prob: 1.00000000
Doc 300: Topic 26 (Auto: Virosomes; Descriptive: Virosomes), Prob: 0.12127606
Doc 301: Topic 26 (Auto: Virosomes; Descriptive: Virosomes), Prob: 1.00000000
Doc 302: Topic 45 (Auto: Med; Descriptive: Med), Prob: 1.00000000
Doc 303: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 304: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 0.89999597
Doc 305: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 1.00000000
Doc 306: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 1.00000000
Doc 307: Topic 12 (Auto: Vaccine; Descriptive: Vaccine – Polyelectrolytes), Prob: 0.77432634
Doc 308: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 309: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 310: Topic 0 (Auto: Vaccines; Descriptive: Vaccines – Mf59), Prob: 1.00000000
Doc 311: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 312: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 313: Topic 42 (Auto: Mucosal; Descriptive: Mucosal), Prob: 1.00000000
Doc 314: Topic 13 (Auto: Anti; Descriptive: Anti), Prob: 1.00000000
Doc 315: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 0.67824244
Doc 316: Topic 42 (Auto: Mucosal; Descriptive: Mucosal), Prob: 1.00000000
Doc 317: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 0.70774075
Doc 318: Topic 17 (Auto: Influenza; Descriptive: Influenza), Prob: 0.58596488
Doc 319: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 0.35310145
Doc 320: Topic 21 (Auto: Vaccine; Descriptive: Vaccine – Hiv), Prob: 0.74121216
Doc 321: Topic 21 (Auto: Vaccine; Descriptive: Vaccine – Hiv), Prob: 1.00000000
Doc 322: Topic 11 (Auto: Paralysis; Descriptive: Paralysis), Prob: 1.00000000
Doc 323: Topic 32 (Auto: Vaccine; Descriptive: Vaccine – Adjuvant), Prob: 1.00000000
